Back to OTA.org

OTA's premier resource for online orthopaedic trauma education.

otaonline.org

2023 On-Demand Annual Meeting Podium Session I: Hip Fractures and Infection I

5 (2 votes)

Comparison of the Effect of Intravenous and Locally Injected Tranexamic Acid on Blood Transfusion and Complications in Fragility Hip Fractures
An Early Coagulation Factor Dominant Hypercoagulability Is Followed by a Prolonged Platelet-Dominant Hypercoagulability in Patients Requiring Hip Fracture Surgery
Tranexamic Acid Administered at Time of Hospital Admission Does Not Decrease Transfusion Rates or Blood Loss for Extracapsular Hip Fractures: A Double-Blinded Randomized Clinical Trial
Safety and Efficiency of Tranexamic Acid on Bleeding in Neck of Femur Fractures: A Double Blind Randomized Controlled Study
Outcomes in Hip Fracture Surgery in Geriatric Patients Receiving Direct Oral Anticoagulation: Should We Delay?
Unipolar Hemiarthroplasty, Bipolar Hemiarthroplasty, or Total Hip Arthroplasty for Hip Fracture in Older Individuals
Long Versus Short Intramedullary Nails for Trochanteric Hip Fractures: A Secondary Analysis of the INSITE Trial

Key:

Complete
Failed
Available
Locked
Comparison of the Effect of Intravenous and Locally Injected Tranexamic Acid on Blood Transfusion and Complications in Fragility Hip Fractures
Recorded 10/19/2023  |   Closed captions available
Recorded 10/19/2023  |   Closed captions available Comparison of the Effect of Intravenous and Locally Injected Tranexamic Acid on Blood Transfusion and Complications in Fragility Hip Fractures Author: Stephen Davis, MD
An Early Coagulation Factor Dominant Hypercoagulability Is Followed by a Prolonged Platelet-Dominant Hypercoagulability in Patients Requiring Hip Fracture Surgery
Select the "View On-Demand Recording" button to begin.  |   Closed captions available
Select the "View On-Demand Recording" button to begin.  |   Closed captions available An Early Coagulation Factor Dominant Hypercoagulability Is Followed by a Prolonged Platelet-Dominant Hypercoagulability in Patients Requiring Hip Fracture Surgery Author: Prism Schneider, MD, PhD
Tranexamic Acid Administered at Time of Hospital Admission Does Not Decrease Transfusion Rates or Blood Loss for Extracapsular Hip Fractures: A Double-Blinded Randomized Clinical Trial
Recorded 10/19/2023  |   Closed captions available
Recorded 10/19/2023  |   Closed captions available Tranexamic Acid Administered at Time of Hospital Admission Does Not Decrease Transfusion Rates or Blood Loss for Extracapsular Hip Fractures: A Double-Blinded Randomized Clinical Trial Author: Rachel Honig, MD
Safety and Efficiency of Tranexamic Acid on Bleeding in Neck of Femur Fractures: A Double Blind Randomized Controlled Study
Recorded 10/19/2023  |   Closed captions available
Recorded 10/19/2023  |   Closed captions available Safety and Efficiency of Tranexamic Acid on Bleeding in Neck of Femur Fractures: A Double Blind Randomized Controlled Study Author: Marie G. Kansayisa, MD, MMED
Outcomes in Hip Fracture Surgery in Geriatric Patients Receiving Direct Oral Anticoagulation: Should We Delay?
Recorded 10/19/2023  |   Closed captions available
Recorded 10/19/2023  |   Closed captions available Outcomes in Hip Fracture Surgery in Geriatric Patients Receiving Direct Oral Anticoagulation: Should We Delay? Author: Devon T. Brameier, BMBCh, BSc
Unipolar Hemiarthroplasty, Bipolar Hemiarthroplasty, or Total Hip Arthroplasty for Hip Fracture in Older Individuals
Recorded 10/19/2023  |   Closed captions available
Recorded 10/19/2023  |   Closed captions available Unipolar Hemiarthroplasty, Bipolar Hemiarthroplasty, or Total Hip Arthroplasty for Hip Fracture in Older Individuals Author: Kanu Okike, MD
Long Versus Short Intramedullary Nails for Trochanteric Hip Fractures: A Secondary Analysis of the INSITE Trial
Recorded 10/24/2024  |  60 minutes  |   Closed captions available
Recorded 10/24/2024  |  60 minutes  |   Closed captions available Long Versus Short Intramedullary Nails for Trochanteric Hip Fractures: A Secondary Analysis of the INSITE Trial Author: Emil H. Schemitsch, MD, FIOTA